Werkgroep Cardiologische centra Nederland

COMPASS (Completed)

A randomized controlled trial of rivaroxaban for the prevention of cardiovascular events in patients with coronary or peripheral artery disease
Medicine
rivaroxaban
Population
ASCVD
Phase
III
Starting year
2013
More information
ClinicalTrials.gov

Publications: COMPASS

Publications by WCN study

Publications WCN studies by WCN member